NDC 72288-112

Basic Care Eye

Tetrahydrozoline Hcl, Zinc Sulfate

Basic Care Eye is a Ophthalmic Solution/ Drops in the Human Otc Drug category. It is labeled and distributed by Amazon.com Services Llc. The primary component is Tetrahydrozoline Hydrochloride; Zinc Sulfate, Unspecified Form.

Product ID72288-112_475f8687-20fc-48fd-88d0-0bb175a1e635
NDC72288-112
Product TypeHuman Otc Drug
Proprietary NameBasic Care Eye
Generic NameTetrahydrozoline Hcl, Zinc Sulfate
Dosage FormSolution/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2021-07-22
Marketing CategoryOTC MONOGRAPH FINAL /
Application Numberpart349
Labeler NameAmazon.com Services LLC
Substance NameTETRAHYDROZOLINE HYDROCHLORIDE; ZINC SULFATE, UNSPECIFIED FORM
Active Ingredient Strength1 mg/mL; mg/mL
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 72288-112-05

1 BOTTLE, DROPPER in 1 CARTON (72288-112-05) > 15 mL in 1 BOTTLE, DROPPER
Marketing Start Date2021-07-22
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Basic Care Eye" or generic name "Tetrahydrozoline Hcl, Zinc Sulfate"

NDCBrand NameGeneric Name
72288-049Basic Care EyePolyethylene Glycol, Propylene Glycol
72288-112Basic Care Eyetetrahydrozoline hcl, zinc sulfate
72288-680Basic Care Eyedextran 70, polyethylene glycol 400, povidone, tetrahydrozoline hydrochloride
69842-611CVS Astringent EyeTetrahydrozoline HCl, Zinc sulfate
46122-602GNP Eye Drops Seasonal Relieftetrahydrozoline HCl, zinc sulfate
50804-121GoodSense Eye Drops Irritation Relieftetrahydrozoline HCl, zinc sulfate
67091-283Irritation Relief EyeTetrahydrozoline HCl, Zinc sulfate
37205-138LEADER RELIEF EYETETRAHYDROZOLINE HCL, ZINC SULFATE
67510-0665Seasonal itchy and Red eye relieftetrahydrozoline HCl, Zinc sulfate
67510-0651Soundbody Seasonal itchy and Red eye relieftetrahydrozoline HCl, Zinc sulfate
36800-855Topcare Health Ultra Itch Relief Astringent Eye Dropstetrahydrozoline HCl, zinc sulfate

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.